fig3
Figure 3. Summary of the different pathways involved in the anti-HCC activity of myricetin (created with BioRender.com). ↑: increase; ↓: decrease. HCC: Hepatocellular carcinoma; YAP/TAZ: yes-associated protein/ transcriptional coactivator with PDZ-binding motif; MARCH1: membrane-associated RING-CH-1; PARP: poly (ADP-ribose) polymerases; ROS: reactive oxygen species; ER: endoplasmic reticulum.
